Journals / İstanbul Kuzey Klinikleri / 2019 / Cilt: 6 - Sayı: 3

Lipid profile, atherogenic indices, and their relationship with epicardial fat thickness and carotid intima–media thickness in celiac disease

Pages
242–247
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Chronic inflammation may be responsiblefor this increase along with atherogenic indices.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: In this study, we aimed to investigate the presence of subclinical atherosclerosis by measuring epicardial fatthickness (EFT) and carotid intima–media thickness (cIMT), evaluate low-level inflammation with high-sensitivity C-reactiveprotein (hsCRP), and evaluate whether there is a relationship among lipid profile, atherogenic indices, and hsCRP with thesesubclinical atherosclerosis markers in patients with celiac disease (CD).METHODS: After exclusion and inclusion criteria were applied, 31 patients with CD (24 female, mean age: 39.4±12.3 years)and 32 healthy controls (21 female, mean age: 39.5±4.4 years), totally 63 cases, were recruited.
📊
Key Findings & Data:Inflammatory markers includingerythrocyte sedimentation rate (ESR), hsCRP, and lipid profile were recorded.
💡
Conclusion & Impact:Chronic inflammation may be responsiblefor this increase along with atherogenic indices.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

OBJECTIVE: In this study, we aimed to investigate the presence of subclinical atherosclerosis by measuring epicardial fatthickness (EFT) and carotid intima–media thickness (cIMT), evaluate low-level inflammation with high-sensitivity C-reactiveprotein (hsCRP), and evaluate whether there is a relationship among lipid profile, atherogenic indices, and hsCRP with thesesubclinical atherosclerosis markers in patients with celiac disease (CD).METHODS: After exclusion and inclusion criteria were applied, 31 patients with CD (24 female, mean age: 39.4±12.3 years)and 32 healthy controls (21 female, mean age: 39.5±4.4 years), totally 63 cases, were recruited. Subclinical atherosclerosiswas evaluated with EFT by transthoracic echocardiography and cIMT by ultrasonography. Inflammatory markers includingerythrocyte sedimentation rate (ESR), hsCRP, and lipid profile were recorded. Also, atherogenic indices were calculated:Castelli risk index I and II (TG/HDL-c and LDL-c/HDL-c, respectively), atherogenic index of plasma (AIP; logarithm TG/HDL-c),non-HDL-c (TG-HDL-c), and atherogenic coefficient (AC; non-HDL-c/HDL-c).RESULTS: EFT was significantly higher in the CD group (0.49±0.10 vs. 0.49±0.09; p-value: 0.02). Although cIMT was higherin the patient group, it did not reach statistical significance (0.51±0.08, 0.47±0.08; p-value: 0.10). HDL cholesterol level wasfound to be significantly lower (42.0±8.8 vs. 50.0±13.7; p-value: 0.01), and the plasma atherogenic index was found to besignificantly higher in the patient group (0.98±0.50 vs. 0.62±0.64; p-value: 0.02). hsCRP (3.51±3.18 vs. 1.92±1.40; p-value:0.02) and ESR (17.2±12.8 with 9.7±3.1; p-value: 0.01) were found to be significantly higher in the CD group. Although therewas a significant positive correlation between EFT and hsCRP (r: 0.453; p-value: 0.01), there was a significant negativecorrelation between cIMT and HDL-cholesterol (−0.339; p-value: 0.05), and a significant positive correlation with the othercomponents of the atherogenic index was found.CONCLUSION: The risk of atherosclerosis has been increased in patients with CD. Chronic inflammation may be responsiblefor this increase along with atherogenic indices.

🔖

Cite This Article

BAYCAN, Ö. F., ÖZCAN, F. B., CALİSKAN, M., KOSTEK, O., CAKLİLİ, O., DEMİRCİOGLU, K., DOĞANAY, H. L., SAYAR, S., CALİSKAN, Z., KAHRAMAN, R. (2022). Lipid profile, atherogenic indices, and their relationship with epicardial fat thickness and carotid intima–media thickness in celiac disease. İstanbul Kuzey Klinikleri, Cilt: 6 - Sayı: 3, 242–247. https://ajindex.com/articles/551468

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol 2014
  2. 634– 47. [CrossRef ] 2. Gök G, Sinan ÜY, Özyüncü N, Zoghi M
  3. ELDER-TÜRK Investigators. The prevalence of cardiovascular diseases, risk factors, and cardio- vascular drugtherapy in very elderly Turkish patients admitted to cardiology clinics: A subgroupanalysis of the ELDER-TURK study. Turk Kardiyol Dern Ars 2018
  4. 283–95. [CrossRef ] 3. Raggi P, Genest J, Giles JT, Rayner KJ, Dwivedi G, Beanlands RS, et al. Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions. Atherosclerosis 2018
  5. 98–108. [CrossRef ] 4. Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol 2012
  6. 2045–51. [CrossRef ] 5. Klingenberg R, Aghlmandi S, Räber L, Gencer B, Nanchen D, Heg D, et al. Improved risk stratification of patients with acute coronary syndromes using a combination of hsTnT, NT-proBNP and hsCRP with the GRACE score. Eur Heart J Acute Cardiovasc Care 2018
  7. 129–38. 6. Caliskan M, Erdogan D, Gullu H, Yilmaz S, Gursoy Y, Yildirir A, et al. Impaired coronary microvascular and left ventricular diastolic functions in patients with ankylosing spondylitis. Atherosclerosis 2008
  8. 306– 12. [CrossRef ] 7. Ciftci O, Yilmaz S, Topcu S, Caliskan M, Gullu H, Erdogan D, et al. Impaired coronary microvascular function and increased intima-media thickness in rheumatoid arthritis. Atherosclerosis 2008
  9. 332–7. 8. Caliskan Z, Gokturk HS, Caliskan M, Gullu H, Ciftci O, Ozgur GT, et al. Impaired coronary microvascular and left ventricular diastolic function in patients with inflammatory bowel disease. Microvasc Res 2015
  10. 25–30. [CrossRef ] 9. Farrell RJ, Kelly CP. Celiac sprue. N Engl J Med 2002
  11. 180–8. 10. Sari C, Bayram NA, Doğan FE, Baştuğ S, Bolat AD, Sarı SÖ, et al. The evaluation of endothelial functions in patients with celiac disease. Echocardiography 2012
  12. 471–7. [CrossRef ] 11. De Marchi S, Chiarioni G, Prior M, Arosio E. Young adults with coeliac disease may be at increased risk of early atherosclerosis. Aliment Pharmacol Ther 2013
  13. 162–9. [CrossRef ] 12. Tok D, Kadife I, Turak O, Ozcan F, Başar N, Cağlı K, et al. Increased epicardial fat thickness is associated with low grade systemicinflammation in metabolic syndrome. Turk Kardiyol Dern Ars 20